These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32938972)

  • 1. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
    Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
    Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique profile of serum cytokines in type 1 autoimmune pancreatitis and chronic rhinosinusitis.
    Yoshikawa T; Minaga K; Hara A; Sekai I; Otsuka Y; Takada R; Kamata K; Watanabe T; Kudo M
    Asian Pac J Allergy Immunol; 2024 Jun; 42(2):154-158. PubMed ID: 33638626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.
    Minaga K; Watanabe T; Hara A; Yoshikawa T; Kamata K; Kudo M
    Front Immunol; 2021; 12():713779. PubMed ID: 34367181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
    Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
    World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free light chain assessment in type 1 autoimmune pancreatitis.
    Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
    Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-35 promotes the differentiation of regulatory T cells and suppresses Th2 response in IgG4-related type 1 autoimmune pancreatitis.
    Ito T; Tanaka T; Nakamaru K; Tomiyama T; Yamaguchi T; Ando Y; Ikeura T; Fukui T; Uchida K; Nishio A; Okazaki K
    J Gastroenterol; 2020 Aug; 55(8):789-799. PubMed ID: 32377945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Dysbiosis and Autoimmune Pancreatitis.
    Yoshikawa T; Watanabe T; Kamata K; Hara A; Minaga K; Kudo M
    Front Immunol; 2021; 12():621532. PubMed ID: 33833754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis.
    Rogger TM; De Marchi G; Brozzi L; Amodio A; Orsolini G; de Pretis N; Conti Bellocchi MC; Crinò SF; Gabbrielli A; Ciccocioppo R; Frulloni L
    Pancreas; 2021 Jul; 50(6):879-881. PubMed ID: 34347736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.
    Okazaki K
    Dig Dis Sci; 2019 Sep; 64(9):2385-2394. PubMed ID: 31363956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease.
    Watanabe T; Minaga K; Kamata K; Kudo M; Strober W
    Trends Immunol; 2018 Nov; 39(11):874-889. PubMed ID: 30401468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in IgG4-related autoimmune pancreatitis.
    Yang X; Zhou H; Wang W; Yan C; Ji G
    Pathol Res Pract; 2024 May; 257():155331. PubMed ID: 38678849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease.
    Okazaki K; Ikeura T; Uchida K
    Mod Rheumatol; 2023 Mar; 33(2):237-241. PubMed ID: 35737955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant CA 19-9 elevation in IgG4-related autoimmune pancreatitis - A diagnostic dilemma.
    Farrukh L; Akhtar MF; Waqar HH; Peredo-Wende R
    Am J Med Sci; 2024 Jan; 367(1):67-71. PubMed ID: 37714269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet aggravates experimental autoimmune pancreatitis through the activation of type I interferon signaling pathways.
    Sekai I; Minaga K; Hara A; Otsuka Y; Kurimoto M; Omaru N; Okai N; Masuta Y; Takada R; Yoshikawa T; Kamata K; Kudo M; Watanabe T
    Biochem Biophys Res Commun; 2022 Dec; 637():189-195. PubMed ID: 36403482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas.
    Yoshikawa T; Minaga K; Hara A; Sekai I; Kurimoto M; Masuta Y; Otsuka Y; Takada R; Kamata K; Park AM; Takamura S; Kudo M; Watanabe T
    Int Immunol; 2022 Dec; 34(12):621-634. PubMed ID: 36044992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis.
    Uchida K; Okazaki K
    J Gastroenterol; 2018 Apr; 53(4):475-483. PubMed ID: 29460239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IFN-α-IL-33 Axis as Possible Biomarkers in IgG4-Related Disease.
    Minaga K; Watanabe T; Kamata K; Takenaka M; Yasukawa S; Kudo M
    Am J Gastroenterol; 2019 Jun; 114(6):1002-1003. PubMed ID: 31058651
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-1 family cytokines and receptors in IgG4-related disease.
    Capecchi R; Italiani P; Puxeddu I; Pratesi F; Tavoni A; Boraschi D; Migliorini P
    Cytokine; 2018 Feb; 102():145-148. PubMed ID: 28823915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid Dendritic Cell Activation and IFN-α Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis.
    Arai Y; Yamashita K; Kuriyama K; Shiokawa M; Kodama Y; Sakurai T; Mizugishi K; Uchida K; Kadowaki N; Takaori-Kondo A; Kudo M; Okazaki K; Strober W; Chiba T; Watanabe T
    J Immunol; 2015 Oct; 195(7):3033-44. PubMed ID: 26297761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells.
    Watanabe T; Yamashita K; Arai Y; Minaga K; Kamata K; Nagai T; Komeda Y; Takenaka M; Hagiwara S; Ida H; Sakurai T; Nishida N; Strober W; Kudo M
    J Immunol; 2017 May; 198(10):3886-3896. PubMed ID: 28373582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.